Wockhardt is currently trading at Rs. 459.25, down by 4.20 points or 0.91% from its previous closing of Rs. 463.45 on the BSE.
The scrip opened at Rs. 461.90 and has touched a high and low of Rs. 462.90 and Rs. 454.90 respectively. So far 37387 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 804.50 on 26-May-2021 and a 52 week low of Rs. 287.00 on 10-Nov-2020.
Last one week high and low of the scrip stood at Rs. 474.30 and Rs. 432.25 respectively. The current market cap of the company is Rs. 5070.36 crore.
The promoters holding in the company stood at 68.04%, while Institutions and Non-Institutions held 2.93% and 29.02% respectively.
Wockhardt has reported net loss at Rs 63.70 crore for the quarter ended September 30, 2021 as compared to net loss of Rs 57.38 crore for the same quarter in the previous year. Total income of the company increased by 1.52% at Rs 314.63 crore for Q2FY22 as compared to Rs 309.92 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported multi fold rise in net profit at Rs 37.17 crore for the quarter under review as compared to net profit of Rs 3.29 crore for the same quarter in the previous year. Total income of the company increased by 18.75% at Rs 867
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1861.70 |
Dr. Reddys Lab | 1389.35 |
Cipla | 1506.15 |
Lupin | 2228.00 |
Zydus Lifesciences | 972.70 |
View more.. |